HIGHLIGHTS
- who: Guangxu Xiao et al. from the Jinan University, China have published the article: CXCR1 and its downstream NF-u03baB inflammation signaling pathway as a key target of Guanxinning injection for myocardial ischemia/reperfusion injury, in the Journal: (JOURNAL)
- what: The authors evaluated the therapeutic effects of GXNI through the mouse model with myocardial ischemia/reperfusion injury (MIRI), and revealed the potential mechanisms of GXNI in the treatment of AMI in combination with RNA-seq and network pharmacological analysis, which revealed that CXCR1 plays a key Frontiers in Immunology To enhance the clinical implications of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.